Cicadea Biotech
Cicadea Biotech provides innovative PCR testing strategies and services for microbe detection and gene detection, serving as a Contract Research Organization for corporate and government clients. Their mission is to improve food safety, animal health, plant health, and human health using PCR technology platforms. They develop custom PCR assays, offer high-throughput testing, and conduct genomic DNA analysis, with a focus on rapid, accurate, and tailored solutions for pathogen and gene detection.
Industries
Nr. of Employees
small (1-50)
Cicadea Biotech
Products
PCR detection kits with quantitative standards
Kits designed for detection of specified bacterial targets that include known standard DNAs for quantification and assay controls.
PCR detection kits with quantitative standards
Kits designed for detection of specified bacterial targets that include known standard DNAs for quantification and assay controls.
Services
Design and validation of customized PCR assays for microbial or gene targets based on provided DNA sequences; includes optimization and QC reporting.
Laboratory testing services offering high-throughput singleplex and multiplex PCR runs for sample screening and quantification.
ddPCR assays for sensitive detection and absolute quantification of low-frequency mutations and pathogen targets.
Scaled DNA extraction workflows and genomic DNA analyses for bacterial and other organism samples at industrial throughput.
Advisory services on sampling methods, nucleic acid isolation, RT-PCR workflows, data analysis and implementation of testing schemes (including pandemic response testing guidance).
Validation of assays under standardized QC guidelines and planning for offering tests as Laboratory Developed Tests (LDTs) with pathways for pursuing regulatory approvals as in vitro diagnostic devices.
Design and validation of customized PCR assays for microbial or gene targets based on provided DNA sequences; includes optimization and QC reporting.
Laboratory testing services offering high-throughput singleplex and multiplex PCR runs for sample screening and quantification.
ddPCR assays for sensitive detection and absolute quantification of low-frequency mutations and pathogen targets.
Scaled DNA extraction workflows and genomic DNA analyses for bacterial and other organism samples at industrial throughput.
Advisory services on sampling methods, nucleic acid isolation, RT-PCR workflows, data analysis and implementation of testing schemes (including pandemic response testing guidance).
Validation of assays under standardized QC guidelines and planning for offering tests as Laboratory Developed Tests (LDTs) with pathways for pursuing regulatory approvals as in vitro diagnostic devices.
Expertise Areas
- PCR assay development
- Molecular diagnostics
- Pathogen detection and environmental microbiology
- High-throughput genotyping
Key Technologies
- Conventional PCR
- Realtime PCR (qPCR)
- Droplet digital PCR (ddPCR)
- Endpoint PCR
News & Updates
Cicadea Biotech announced the award of a Phase I NSF SBIR/STTR grant to support the development of a urine test for kidney cancer detection.
Research on a novel urinary biomarker for kidney cancer detection and surveillance.
Development of PCR methods for early detection of Legionella bacteria to prevent disease outbreaks.
PCR testing for Mycobacterium to prevent hypersensitivity pneumonia outbreaks.
Development of PCR methods for early detection of Legionella bacteria to prevent disease outbreaks.
Cicadea Biotech announced the award of a Phase I NSF SBIR/STTR grant to support the development of a urine test for kidney cancer detection.
Research on a novel urinary biomarker for kidney cancer detection and surveillance.
Development of PCR methods for early detection of Legionella bacteria to prevent disease outbreaks.
PCR testing for Mycobacterium to prevent hypersensitivity pneumonia outbreaks.
Development of PCR methods for early detection of Legionella bacteria to prevent disease outbreaks.